AP Celgene is acquiring Juno Therapeutics, a company developing personalized cancer treatments in a deal worth $ 9 billion. It’s the second deal in 2018 for the biotech giant, which has been under pressure from investors. The highly personalized treatments Juno makes, called CAR T-cell therapy, are at the beginning of what some are calling “a big […]
Tag: Celgene
Celgene is reportedly in talks to buy a $5.5 billion cancer drugmaker
Reuters Celgene is in talks to acquire Juno Therapeutics, The Wall Street Journal reported on Tuesday. If the deal materializes, it’d be the second in 2018 for the biotech giant, which has been under pressure from investors. Juno is known for its experimental treatments that harness the body’s immune system to treat cancer. Biotech giant […]
